On 2 July 2026, IQM Quantum Computers began trading on Nasdaq (ticker IQMX) following its business combination with Real Asset Acquisition Corp., marking the first European quantum computing company to list on a major US exchange1,2. IQM entered public markets with a reported pro forma cash position of approximately €337 million and momentum from its worldwide sales of 23 quantum computers, which IQM says is more than any other quantum manufacturer1.
Crossing the threshold - with caution
At one level, IQM’s Nasdaq debut is a clear milestone. It signals that at least part of the European quantum sector has evolved to a significant stage in terms of credible scaling narratives and clear commercial pathways.
Yet the tone surrounding the listing is notably cautious. As has been highlighted in some coverage3, IQM’s own prospectus includes the stark warning that “large-scale commercial traction of quantum computing technology may never occur”4. That statement, stark though consistent with the risk-disclosure style of public filings, reflects the central tension in the sector: significant technical progress and early commercial engagement, but persistent uncertainty about long-term outlook.
This tension is reinforced by IQM’s operating metrics. The company expanded its customer base from 8 in 2024 to 22 in 2025, demonstrating growing adoption across research, high-performance computing, and emerging private-sector use cases3. However, meaningful scaling of demand is still widely believed to depend on achieving “quantum advantage” — the point at which quantum systems outperform classical alternatives for commercially relevant problems. That milestone remains technically uncertain and, crucially, difficult to time.
The result is a public listing that looks less like a culmination and more like a transition: from private optimism to public scrutiny.
A European inflection point - from research strength to market discipline
Beyond the company itself, IQM’s listing carries broader significance for the European quantum ecosystem.
For several years, Europe has been characterised by strong academic output, public funding, and a growing base of start-ups — but comparatively fewer scale-ups able to compete globally, particularly in capital-intensive hardware segments. IQM’s move into US public markets suggests that this dynamic may be beginning to shift.
Importantly, the structure of the transaction matters. IQM has accessed US capital markets while maintaining its European base, reinforcing the idea that European quantum companies do not necessarily need to relocate to participate in global capital flows. However, public markets introduce a different kind of discipline. Venture capital can tolerate long timelines and technical uncertainty; public investors are typically less patient. More regular reporting, market valuations, and risk disclosures force companies to articulate not only their technological vision, but also the credibility of their path to commercialisation.
In this sense, IQM’s listing may be better understood as a stress test for the European quantum model: can a company built in a research-driven ecosystem sustain investor confidence in a public market?
Conclusion - European quantum faces US reality
From my perspective, IQM’s Nasdaq debut does not quite signal that the European quantum computing sector has arrived at commercial maturity. Rather, it marks a transition: from a mode defined largely by research milestones and private investment to one operating under the visibility of a major US exchange.
That shift brings greater transparency. Technical uncertainty, long development timelines, and questions around real-world demand may no longer be implicit, but rather explicitly acknowledged in investor communications and market reactions.
For the European quantum sector more broadly, this moment is less about validation and more about accountability. Public listings test not just technological promise, but the credibility of commercial pathways and the ability to sustain momentum over time.
In that sense, IQM’s listing may prove to be an early indicator of what comes next: a phase in which European quantum companies are judged not only on the technical excellence they might achieve, but on how convincingly they can navigate the long road from innovation to impact.
[4] https://investors.iqm.tech/static-files/ab06ace2-6744-4d6f-b742-20442cc23ff7
Josh is a patent technical assistant working as part of the Engineering practice group. Josh graduated from the University of Oxford with an integrated Master’s degree in Chemistry (MChem). For his Master’s research project he worked in quantum chemistry, conducting spin dynamics simulations relating to the radical pair mechanism of avian magnetoreception (the ‘magnetic sense’ with which birds can navigate). His Master’s report on the effect of weak magnetic fields on radical pair reactions was runner-up for a departmental thesis prize.
Email: josh.blunsden@mewburn.com
.png)